HALO
HALOZYME THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$122.50
+0.54%0
Insider buys (3m)
38
Insider sells (3m)
-$22.1M
Net value (3m)
+59.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 200 | $114 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 2,300 | $108 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 8,600 | $111 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 6,000 | $109 |
| Oct 8, 2026 | Connaughton Bernadette · director | A-Award | 3,796 | $0.00 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 9,920 | $110 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 11,900 | $110 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 3,090 | $109 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 10,300 | $112 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 4,810 | $108 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 1,780 | $111 |
| Oct 8, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 900 | $113 |
| Oct 2, 2026 | Posard Matthew L. · director | Sale | 1,100 | $110 |
| Oct 2, 2026 | Posard Matthew L. · director | Sale | 730 | $107 |
| Oct 2, 2026 | Daly James M · director | A-Award | 1,169 | $0.00 |
| Oct 2, 2026 | Daly James M · director | A-Award | 1,775 | $107 |
| Oct 2, 2026 | Posard Matthew L. · director | Sale | 3,300 | $108 |
| Oct 2, 2026 | Posard Matthew L. · director | Sale | 100 | $110 |
| Sep 17, 2026 | Posard Matthew L. · director | Sale | 3,100 | $106 |
| Sep 17, 2026 | Posard Matthew L. · director | Sale | 8,896 | $108 |
| Sep 17, 2026 | Posard Matthew L. · director | Sale | 4,000 | $109 |
| Sep 17, 2026 | Posard Matthew L. · director | Sale | 3,000 | $107 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 4,508 | $108 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 100 | $109 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 15,492 | $107 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 14,588 | $107 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 13,304 | $107 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18 |
| Sep 11, 2026 | Torley Helen · director, officer: PRESIDENT AND CEO | Sale | 6,596 | $108 |
Institutional positioning
13F filings over the trailing two quarters
New 211Increased 501Reduced 437Sold out 72
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 13,271,095 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 13,265,053 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 5,351,312 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 5,299,008 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,271,218 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 5,249,206 | May 8, 2026 |
| STATE STREET CORP | Increased | 5,179,434 | Sep 22, 2026 |
| STATE STREET CORP | Reduced | 4,937,854 | May 15, 2026 |
| INVESCO LTD. | Increased | 4,012,494 | May 12, 2026 |
| Invesco Ltd. | Reduced | 3,177,997 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 2,913,109 | May 18, 2026 |
| MORGAN STANLEY | Increased | 2,832,594 | Aug 13, 2026 |
| Boston Partners | Increased | 2,773,568 | Aug 4, 2026 |
| BANK OF AMERICA CORP /DE/ | Reduced | 2,740,561 | Aug 14, 2026 |
| BOSTON PARTNERS | Increased | 2,683,683 | May 11, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 8, 2026